# The impact of cholesteryl ester transfer protein on the progression of cutaneous leishmaniasis

**Authors:** Francisca Elda Batista-Dantas, Christiane Yumi Ozaki, Kelly Gomes Santana, Valéria Sutti Nunes, Bernardina Amorin Uscata, Cinthia Siess-Portugal, Luiza Campos Reis, Edite H. Yamashiro-Kanashiro, Wagner Luiz Tafuri, Amaro Nunes Duarte-Neto, Mirian Nacagami Sotto, Hiro Goto, Patrícia Miralda Cazita

PMC · DOI: 10.3389/fimmu.2024.1389551 · Frontiers in Immunology · 2024-06-20

## TL;DR

This study shows that the presence of CETP helps reduce parasitism and improve healing in cutaneous leishmaniasis by modulating the immune response.

## Contribution

The study demonstrates a novel role for CETP in modulating inflammation and infection outcomes in cutaneous leishmaniasis.

## Key findings

- CETP mice showed reduced lesion progression and parasitism compared to wild-type mice.
- CETP presence increased M2 macrophage markers and altered lipid profiles during infection.
- In vitro experiments confirmed CETP's role in reducing parasite load and modulating immune responses.

## Abstract

Pathogenesis of cutaneous leishmaniases involves parasite growth, persistent inflammation, and likely participation of lipoproteins (LP). The cholesteryl ester transfer protein (CETP), involved in LP remodeling, has been shown to participate in the inflammatory response and the evolution of infectious conditions.

We evaluated the impact of the presence of CETP on infection by Leishmania (L.) amazonensis in an experimental model of cutaneous leishmaniasis using C57BL6/J mice transgenic for human CETP (CETP), having as control their littermates that do not express the protein, wild-type (WT) mice. The progression of the lesion after infection in the footpad was monitored for 12 weeks. Two groups of animals were formed to collect the plantar pad in the 4th and 12th week post-infection.

The lesion increased from the 3rd week onwards, in both groups, with a gradual decrease from the 10th week onwards in the CETP group compared to the WT group, showing a reduction in parasitism and an improvement in the healing process, a reduction in CD68+ cells, and an increase in CD163+ and CD206, characterizing a population of M2 macrophages. A reduction in ARG1+ cells and an increase in INOS+ cells were observed. During infection, the LP profile showed an increase in triglycerides in the VLDL fraction in the CETP group at 12 weeks. Gene expression revealed a decrease in the CD36 receptor in the CETP group at 12 weeks, correlating with healing and parasite reduction. In vitro, macrophages derived from bone marrow cells from CETP mice showed lower parasite load at 48 h and, a reduction in arginase activity at 4 h accompanied by increased NO production at 4 and 24 h compared to WT macrophages, corroborating the in vivo findings.

The data indicate that the presence of CETP plays an important role in resolving Leishmania (L.) amazonensis infection, reducing parasitism, and modulating the inflammatory response in controlling infection and tissue repair.

## Linked entities

- **Genes:** CD36 (CD36 molecule (CD36 blood group)) [NCBI Gene 948], ARG1 (arginase 1) [NCBI Gene 383], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843]
- **Proteins:** CD68 (CD68 molecule), CD163 (CD163 molecule), MRC1 (mannose receptor C-type 1)
- **Diseases:** cutaneous leishmaniasis (MONDO:0005446)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, CETP (cholesteryl ester transfer protein) [NCBI Gene 1071] {aka BPIFF, HDLCQ10}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, ISYNA1 (inositol-3-phosphate synthase 1) [NCBI Gene 51477] {aka INO1, INOS, IPS, IPS 1, IPS-1}, ARG1 (arginase 1) [NCBI Gene 383]
- **Diseases:** cutaneous leishmaniases (MESH:D016773), infectious (MESH:D003141), inflammation (MESH:D007249), infection (MESH:D007239)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11222338/full.md

## Figures

15 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11222338/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC11222338/full.md

---
Source: https://tomesphere.com/paper/PMC11222338